IL36G and Alzheimer disease: However, the expression levels of both serum IL-36γ and skin IL-36γ increased in AD and mycosis fungoides/Sézary syndrome, and no statistically significant differences were found, which means it is not a perfect biomarker for AD diagnosis (23).